(Q39754136)

14 September 2017

title

Halofuginone inhibits Smad3 phosphorylation via the PI3K/Akt and MAPK/ERK pathways in muscle cells: effect on myotube fusion (English)

1 reference

14 September 2017

0 references

Suzy Roffe

1

1 reference

14 September 2017

Yosey Hagai

series ordinal

2

1 reference

14 September 2017

Mark Pines

series ordinal

3

1 reference

14 September 2017

Orna Halevy

series ordinal

4

1 reference

14 September 2017

language of work or name

English

0 references

publication date

11 January 2010

1 reference

Experimental Cell Research

14 September 2017

published in

1 reference

14 September 2017

volume

316

1 reference

14 September 2017

issue

6

1 reference

14 September 2017

page(s)

1061-1069

1 reference

14 September 2017

cites work

The muscular dystrophies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Muscle diseases: the muscular dystrophies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Dystrophin and muscular dystrophy: past, present, and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Transforming growth factor-beta2 is elevated in skeletal muscle disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

TGF-beta signaling and the fibrotic response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Transforming growth factor-beta-induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Negative regulation of TGF-beta receptor/Smad signal transduction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

PKB/Akt modulates TGF-beta signalling through a direct interaction with Smad3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Identification and characterization of ERK MAP kinase phosphorylation sites in Smad3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

ERK2 is required for efficient terminal differentiation of skeletal myoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Halofuginone: a novel antifibrotic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad3 activation in fibroblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Halofuginone inhibits tumor growth in the polyoma middle T antigen mouse via a thrombospondin-1 independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-beta signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Myofibroblasts in pulmonary and brain metastases of alveolar soft-part sarcoma: a novel target for treatment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Functional resolution of fibrosis in mdx mouse dystrophic heart and skeletal muscle by halofuginone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Involvement of ERK signaling in halofuginone-driven inhibition of fibroblast ability to contract collagen lattices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Low-energy laser irradiation affects satellite cell proliferation and differentiation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Pattern of Pax7 expression during myogenesis in the posthatch chicken establishes a model for satellite cell differentiation and renewal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Regulation of the growth of multinucleated muscle cells by an NFATC2-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

E47 phosphorylation by p38 MAPK promotes MyoD/E47 association and muscle-specific gene transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Amelioration of radiation-induced fibrosis: inhibition of transforming growth factor-beta signaling by halofuginone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Modulation of Smad2-mediated signaling by extracellular signal-regulated kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Involvement of 3-phosphoinositide-dependent protein kinase-1 in the MEK/MAPK signal transduction pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

TGF-beta and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Control of the eukaryotic cell cycle by MAP kinase signaling pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Halofuginone induces matrix metalloproteinases in rat hepatic stellate cells via activation of p38 and NFkappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Myostatin inhibits myoblast differentiation by down-regulating MyoD expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

Myostatin directly regulates skeletal muscle fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.01.003

10.1016/J.YEXCR.2010.01.003

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference